Gestational Response, Outcomes, and Weight After GLP-1 Use
Recruiting · NCT07743567 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Kansas Medical Center
View the official record on ClinicalTrials.gov →What this trial is about
The goal of this observational study is to learn if using GLP-1RA medications for weight loss before pregnancy influences gestational weight gain and pregnancy outcomes. The main aims of the study are to: * Compare gestational weight gain between women with preconception GLP-1RA exposure and those without exposure. * Compare obstetrical outcomes between women with preconception GLP-1RA exposure and those without exposure. Researchers will compare pregnant women with a history of GLP-1RA use to pregnant women who have not used a GLP-1RA to compare differences. Participants will be asked to complete questionnaires at multiple timepoints during and after pregnancy that ask questions about medication history, thoughts and feelings around food, etc.
Who can take part
Inclusion criteria
- Adult women
- Less than or equal to 20 weeks gestation at first visit
- English speaking
Exclusion criteria
- \<18 years at time of initial visit
- Type 2 diabetes
- History of bariatric surgery
- Multiple gestation
- Cannot consent for themselves
- Cannot read and speak English
- Incarcerated
Where it is running
1 location listed across 1 US state.
- University of Kansas Medical Center - Kansas City, Kansas, United States